Class Action Filed Against Maker Of Generic Anticholesterol Drug

A putative class action has been lodged in New Jersey against the Princeton-based maker of the cholesterol-reducing drug Atorvastatin, which was found to be tainted with glass particles.

This article requires free registration

This article requires free registration to The New Jersey Law Journal. Please sign in or register to read the full text.